AI-integrated capsule gastroscopy (ACG) may help expand screening access, reduce patient barriers, and improve resource ...

A risk-based screening strategy shows high efficacy and significant reductions in cost in the detection of upper gastrointestinal cancers compared with conventional universal screening, results from a ...

Please provide your email address to receive an email when new articles are posted on . The swallowed capsule detected the presence of blood with a sensitivity and specificity of 92.9% and 90.6%, ...

Please provide your email address to receive an email when new articles are posted on . Evidence for metoclopramide use in upper GI bleeding is very low, with few published trial data. Existing data ...

The BREAKWATER trial demonstrated the efficacy of a BRAF-targeted regimen using FOLFIRI, offering a neuropathy-free option for metastatic colorectal cancer patients. HERIZON-GEA-01 trial results ...

For patients taking GLP-1 receptor agonists (GLP-1 RAs), the use of proton pump inhibitors (PPIs) is associated with an increased risk for gastrointestinal (GI) adverse effects, according to research ...

Our spotlight call highlights key areas where dedicated clinical research efforts focused on upper gastrointestinal cancers of unmet need can improve patient outcomes.